MEDIA ADVISORY: Ultragenyx Canada Announces Health Canada Approval of a Second Indication for Crysvita™ (Burosumab Injection) for the Treatment of Tumour Induced Osteomalacia in Adults

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence